Assessment of Urostomy Parastomal Herniation Forces Using Incisional Prevention Strategies with an Abdominal Fascia Model
https://t.co/ywTmqvIIfw
@KDibo900 @yashusxdcr@schadegr#UroSoMe#Openaccess#Openscience
Ken Cleary opted for high-frequency focused ultrasound treatment (#HIFU) for his #prostatecancer, a leading-edge technology that Fred Hutch was first to offer in the area. A biopsy showed that Cleary’s cancer was completely cleared by his treatment. https://t.co/iiH3nPRHPd
@yawnyame @KDibo900 @schadegr@SocietyGURS@uwurology@UwUroResidents Congrats Diboro on the J Tate Mason award (1st prize) for this presentation! I have your plaque and will include the picture of me accepting your award on your behalf 😉 (required by Dr Barry)
❄️ Our #12DaysOfGivingSweepstakes is BACK ❄️
Hit that RT button for a chance to win our very first prize, a @JRODshow44 Rookie of the Year Prize Pack thanks to the @MarinersStore!
Must be 18+. No purch. nec. Enter by 11:59pm PT on 12/28/22. https://t.co/rczenxVflu
Excited to have performed the first #HIFU ablation of the prostate today at @uwurology and @UWMedicine with @DanLinMD. Looking forward to having this exciting technology for our patients with #prostatecancer in the #PNW
Thanks to @UMNUrology for hosting Adam Maxwell and I for the Fraley Lectureship! It was great to make new connections and share our work in #histotripsy!
Merck enthusiastically promoting NMIBC use of Pembro.
Really? It works poorly at best. You now what work nicely? But we still can not get enough of?.....BCG...never seen a commercial for BCG
cc @megtirrell
We now have enough #SARSCoV2 genomic data from different states to make some broad conclusions about how the #COVID19 epidemic has unfolded in the US. 1/14
If we're going to manage a #TestTraceIsolate solution to the #COVID19 epidemic, we need a massive scale up in testing. There are some really exciting initiatives here. 1/9
THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on vents, mortality will range from 25-97%". This @JAMA_current study is a great for a JournalClub on "Beware Your Denominator"👇(1/7)
https://t.co/Xsxmi3zIL9